The use of atypical antipsychotics in the treatment of catatonia

European Psychiatry

Volumn 20, Issue 5-6, 2005, Pages 422-429

  Van Den Eede, Filip ^a,b   Van Hecke, Jan ^a,c   Van Dalfsen, Arjen ^a,d   Van Den Bossche, Bart ^a,b   Cosyns, Paul ^a,b   Sabbe, Bernard G C ^a,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Campus Stuivenberg   (Belgium)

^d Mental Health Care WNB   (Netherlands)

^e Psychiatric Hospital St Norbertushuis   (Belgium)

Author keywords

Atypical antipsychotics; Catatonia; Lethal catatonia; Malignant catatonia; Neuroleptic malignant syndrome

Indexed keywords

AMANTADINE; AMISULPRIDE; AMOBARBITAL; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; DANTROLENE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; RISPERIDONE; SERTRALINE; VALPROIC ACID; ZIPRASIDONE;

CATATONIA; CATATONIC SCHIZOPHRENIA; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; HUMAN; LOW DRUG DOSE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 24944518446     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.03.012     Document Type: Short Survey

References (65)

1. R.C. Albucher, J. DeQuardo, and R. Tandon Treatment of catatonia with an anticholinergic agent Biol. Psychiatry 29 1991 508 517
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed 1994 APA Washington, DC
3. J. Ananth, K.S. Burgoyne, R. Gadasalli, and S. Aquino How do the atypical antipsychotics work? J. Psychiatry Neurosci. 26 2001 385 394
4. J. Ananth, S. Parameswaran, S. Gunatilake, K. Burgoyne, and T. Sidhom Neuroleptic malignant syndrome and atypical antipsychotic drugs J. Clin. Psychiatry 65 2004 464 470
5. J. Arnt, and T. Skarsfeldt Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 1998 63 101
6. M. Bahro, C. Kämpf, and J. Strnad Catatonia under medication with risperidone in a 61-year-old patient Acta Psychiatr. Scand. 99 1999 223 226
7. D. Blummer Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings Compr. Psychiatry 38 1997 193 201
8. P. Braunig, S. Kruger, G. Shugar, J. Hoffler, and I. Borner The catatonia rating scale I-development, reliability, and use Compr. Psychiatry 2 2000 147 158
9. G. Bush, M. Fink, G. Petrides, F. Dowling, and A. Francis Catatonia. I. Rating scale and standardized examination Acta Psychiatr. Scand. 93 1996 129 136
10. G. Bush, M. Fink, G. Petrides, F. Dowling, and A. Francis Catatonia II. Treatment with orazepam and electroconvulsive therapy Acta Psychiatr. Scand. 93 1996 137 143
11. B.T. Carroll, and J.W. Lee Catatonia is a risk factor for neuroleptic malignant syndrome J. Clin. Psychiatry 65 2004 1722 1723
12. B.T. Carroll, and R.E. Taylor The nondichotomy between lethal catatonia and neuroleptic malignant syndrome J. Clin. Psychopharmacol. 17 1997 235 236
13. E.M. Cassidy, M. O'Brien, M.F. Osman, J. Finucane, and V. O'Keane Lethal catatonia responding to high-dose olanzapine therapy J. Clin. Psychopharmacol. 15 2001 302 304
14. E. Castillo, R.T. Rubin, and E. Holsboer-Trachsler Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome Am. J. Psychiatry 146 1989 324 328
15. S.N. Caroff, S.C. Mann, E.C. Campbell, and K.A. Sullivan Movement disorders associated with atypical antipsychotic drugs J. Clin. Psychiatry 63 2002 12 19
16. E.H. Cook, K. Olson, and N. Pliskin Response of organic catatonia to risperidone Arch. Gen. Psychiatry 53 1996 82 83
17. G.A. Filice, B.C. McDougall, N. Ercan Fang, and C.J. Billington Neuroleptic malignant syndrome associated with olanzapine Ann. Pharmacother. 32 1998 1158 1159
18. M. Fink Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 39 1996 1 4
19. M. Fink Catatonia: syndrome or schizophrenia subtype? Recognition and treatment J. Neural Transm. 108 2001 637 644
20. M. Fink, and M.A. Taylor Catatonia. A clinicians guide to diagnosis and treatment. 1st ed 2003 Cambridge University Press Cambridge
21. W.W. Fleischhacker, B. Unterweger, J.M. Kane, and H. Hinterhuber The neuroleptic malignant syndrome and its differentiation from lethal catatonia Acta Psychiatr. Scand. 81 1990 3 5
22. G.L. Fricchione Neuroleptic catatonia and its relationship to psychogenic catatonia Biol. Psychiatry 20 1985 304 313
23. R.J. Gurrera Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome Am. J. Psychiatry 156 1999 169 180
24. S. Hasan, and P. Buckley Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique Am. J. Psychiatry 155 1998 1113 1116
25. J.M. Hawkins, K.J. Archer, S.M. Strakowski, and P.E. Keck Somatic treatment of catatonia Int. J. Psychiatry Med. 25 1995 345 369
26. B. Hesslinger, J. Walden, and C. Normann Acute and long-term treatment of catatonia with risperidone Pharmacopsychiatry 34 2001 25 26
27. L. Kahlbaum Die Katatonie oder das Spannungsirresein, Eine klinische Form psychischer Krankheit 2000 Nijmegen: Arts & Boeve (1874)
28. S. Kapur, and P. Seeman Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis Am. J. Psychiatry 158 2001 360 369
29. J.S. Kewalsing, G.M.G.I. Ramaekers, and P.N. Van Harten Neuroleptic malignant syndrome and quetiapine Am. J. Psychiatry 159 2002 149 150
30. M. Koch, S. Chandragiri, S. Rizvi, G. Petrides, and A. Francis Catatonic signs in neuroleptic malignant syndrome Compr. Psychiatry 41 2000 73 75
31. D. Kohen, and M.F. Bristow Atypical antipsychotics and neuroleptic malignant syndrome Br. J. Psychiatry 175 1999 392 393
32. L.C. Kopala, and C. Caudle Acute and longer-term effects of risperidone in a case of first-episode catatonic schizofrenia J. Psychopharmacol. 12 1998 314 317
33. S. Krüger, R.G. Cooke, C.C. Spegg, and P. Bräunig Relevance of the catatonic syndrome to the mixed manic episode J. Affect. Disord. 74 2003 279 285
34. E.C. Lauterbach Catatonia-like events after valproic acid with risperidone and sertraline Neuropsychiatry Neuropsychol. Behav. Neurol. 11 1998 157 163
35. J.W.Y. Lee, and S. Robertson Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report Ann. Clin. Psychiatr. 9 1997 165 169
36. S. Leucht, G. Pitschel-Walz, R.R. Engel, and W. Kissling Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials Am. J. Psychiatry 159 2002 180 190
37. J.L. Levenson Neuroleptic malignant syndrome Am. J. Psychiatry 142 1985 1137 1145
38. P.M. Llorca, F. Penault, C. Laņon, E. Dufumier, and G. Vaiva Notion de psychose d'hypersensibilit́. Cas particulier de la clozapine Encephale XXV 1999 638 644
39. A. Lopez-Canino, and A. Francis Drug-induced catatonia S.N. Caraoff S.C. Mann A. Francis G.L. Fricchione Catatonia: from psychopathology to neurobiology 2004 American Psychiatric Publishing Arlington 129 139
40. S.C. Mann, S.N. Caroff, H.R. Bleier, W.K.R. Welz, M.A. Kling, and M. Hayashida Lethal catatonia Am. J. Psychiatry 143 1986 1374 1381
41. S.C. Mann, M. Auriacombe, W. Macfadden, S.N. Caroff, E.C. Campbell, and J. Tignol La catatonie ĺthale: aspects cliniques et conduite th́rapeutique. Une revue de la litt́rature Encephale XXVII 2001 213 216
42. F. Mart́nyi, S. Metcalfe, B. Schausberger, and M.R.K. Dossenbach An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms J. Clin. Psychiatry 62 2001 25 27
43. H. Meltzer Multiple neurotransmitters involved in antipsychotic drug action S. Kapur Y. Lecrubier Dopamine in the pathophysiology and treatment of schizophrenia 2003 Martin Dunitz London 177 205
44. D. Naber, R. Holzbach, C. Perro, and H. Hippius Clinical management of clozapine patients in relation to efficacy and side-effects Br. J. Psychiatry 160 1992 54 59
45. G. Northoff Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology J. Neural Transm. 109 2002 1453 1467
46. G. Northoff, A. Koch, J. Wenke, J. Eckert, H. Boker, B. Pflug, and B. Bogerts Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms Mov. Disord. 14 1999 404 416
47. G. Northoff, R. Kotter, F. Baumgart, P. Danos, H. Boeker, and T. Kaulisch Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation Schizophr. Bull. 30 2004 405 427
48. G. Northoff, R. Steinke, C. Czcervenka, R. Krause, S. Ulrich, and P. Danos Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding J. Neurol. Neurosurg. Psychiatry 67 1999 445 450
49. K.L. Philbrick, and T.A. Rummans Malignant catatonia J. Neuropsychiatry Clin. Neurosci. 6 1994 1 13
50. N. Pommepuy, and D. Januel La catatonie: ŕsurgence d'un concept. Une revue de la litt́rature internationale Encephale XXVII 2002 481 492
51. O. Rommel, M. Tegenthoff, W. Widdig, P. Bräunig, and J.P. Malin Organic catatonia following frontal lobe injury: response to clozapine J. Neuropsychiatr. 10 1998 237 238
52. P.I. Rosebush, and M.F. Mazurek Catatonia: re-awakening to a forgotten disorder Mov. Disord. 14 1999 395 397
53. P.I. Rosebush, A.M. Hildebrand, B.G. Furlong, and M.F. Mazurek Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam J. Clin. Psychiatry 51 1990 357 362
54. P.I. Rosebush, T. Stewart, and M.F. Mazurek The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J.Psychiatry 159 1991 709 712
55. B. Singerman, and R. Raheja Malignant catatonia-a continuing reality Ann. Clin. Psychiatry 6 1994 259 266
56. M.A. Taylor, and M. Fink Catatonia in psychiatric classification: a home of is own Am. J. Psychiatry 160 2003 1233 1241
57. G.S. Ungvari, and B.T. Caroll Foundations for the classification of catatonias Mov. Disord 15 2000 180 181
58. G.S. Ungvari, H.F.K. Chiu, L.Y. Chow, B.T.S. Lau, and W.K. Tang Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled crossover study Psychopharmacology 142 1999 393 398 (Berl.)
59. G.S. Ungvari, C.M. Leung, M.K. Wong, and J. Lau Benzodiazepines in the treatment of catatonic syndrome Acta Psychiatr. Scand. 89 1994 285 288
60. A. Valevski, T. Loebl, T. Keren, L. Bodinger, and A. Weizman Response of catatonia to risperidone: two case reports Clin. Neuropharmacol. 24 2001 228 231
61. F. Van Den Eede, and B. Sabbe Catatonia in psychiatric classification Am. J. Psychiatry 161 2004 2327 2328
62. F.M.M.A. Van der Heijden, S. Tuinier, L. Pepplinkhuizen, and W.M.A. Verhoeven Catatonia: the rise and fall of an intriguing psychopathological dimension Acta Neuropsychiatr. 14 2002 111 116
63. D.A.C. White, and A.H. Robins Catatonia: harbinger of the neuroleptic malignant syndrome Br. J. Psychiatry 158 1991 419 421
64. O. Woodburne, L. Nunez, and C.Y. Nunez Use of ziprasidone to treat bipolar-associated catatonia Bipolar Disord. 6 2004 166 167
65. A.W. Yeh, J.W. Lee, T.C. Cheng, J.K. Wen, and W.H. Chen Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report Clin. Neuropharmacol. 27 2004 216 218